CRON
Price
$1.82
Change
+$0.03 (+1.68%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
1B
40 days until earnings call
OGI
Price
$1.03
Change
-$0.01 (-0.96%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
200.85M
Ad is loading...

CRON vs OGI

Header iconCRON vs OGI Comparison
Open Charts CRON vs OGIBanner chart's image
Cronos Group
Price$1.82
Change+$0.03 (+1.68%)
Volume$17.11K
Capitalization1B
Organigram Global
Price$1.03
Change-$0.01 (-0.96%)
Volume$8.56K
Capitalization200.85M
CRON vs OGI Comparison Chart
Loading...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRON vs. OGI commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRON is a Hold and OGI is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (CRON: $1.81 vs. OGI: $1.04)
Brand notoriety: CRON and OGI are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CRON: 62% vs. OGI: 65%
Market capitalization -- CRON: $1B vs. OGI: $200.85M
CRON [@Pharmaceuticals: Other] is valued at $1B. OGI’s [@Pharmaceuticals: Other] market capitalization is $200.85M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRON’s FA Score shows that 0 FA rating(s) are green whileOGI’s FA Score has 0 green FA rating(s).

  • CRON’s FA Score: 0 green, 5 red.
  • OGI’s FA Score: 0 green, 5 red.
According to our system of comparison, CRON is a better buy in the long-term than OGI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRON’s TA Score shows that 3 TA indicator(s) are bullish while OGI’s TA Score has 4 bullish TA indicator(s).

  • CRON’s TA Score: 3 bullish, 5 bearish.
  • OGI’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, OGI is a better buy in the short-term than CRON.

Price Growth

CRON (@Pharmaceuticals: Other) experienced а +0.56% price change this week, while OGI (@Pharmaceuticals: Other) price change was -2.80% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.71%. For the same industry, the average monthly price growth was -0.38%, and the average quarterly price growth was -8.58%.

Reported Earning Dates

CRON is expected to report earnings on May 13, 2025.

OGI is expected to report earnings on Nov 27, 2023.

Industries' Descriptions

@Pharmaceuticals: Other (-1.71% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRON($1.01B) has a higher market cap than OGI($201M). CRON YTD gains are higher at: -10.396 vs. OGI (-35.404). CRON has higher annual earnings (EBITDA): -71.8M vs. OGI (-195.74M). CRON has more cash in the bank: 862M vs. OGI (42.3M). OGI has less debt than CRON: OGI (136K) vs CRON (2.55M). OGI has higher revenues than CRON: OGI (161M) vs CRON (87.2M).
CRONOGICRON / OGI
Capitalization1.01B201M500%
EBITDA-71.8M-195.74M37%
Gain YTD-10.396-35.40429%
P/E RatioN/AN/A-
Revenue87.2M161M54%
Total Cash862M42.3M2,038%
Total Debt2.55M136K1,877%
FUNDAMENTALS RATINGS
CRON vs OGI: Fundamental Ratings
CRON
OGI
OUTLOOK RATING
1..100
639
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8594
PRICE GROWTH RATING
1..100
8090
P/E GROWTH RATING
1..100
5996
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OGI's Valuation (52) in the null industry is in the same range as CRON (57) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to CRON’s over the last 12 months.

OGI's Profit vs Risk Rating (100) in the null industry is in the same range as CRON (100) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to CRON’s over the last 12 months.

CRON's SMR Rating (85) in the Pharmaceuticals Other industry is in the same range as OGI (94) in the null industry. This means that CRON’s stock grew similarly to OGI’s over the last 12 months.

CRON's Price Growth Rating (80) in the Pharmaceuticals Other industry is in the same range as OGI (90) in the null industry. This means that CRON’s stock grew similarly to OGI’s over the last 12 months.

CRON's P/E Growth Rating (59) in the Pharmaceuticals Other industry is somewhat better than the same rating for OGI (96) in the null industry. This means that CRON’s stock grew somewhat faster than OGI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRONOGI
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 17 days ago
73%
Bullish Trend 17 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
73%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FICGX11.33N/A
N/A
Cantor Fitzgerald Large Cap Fcs Cl A
HGORX51.10N/A
N/A
Hartford Growth Opportunities R3
SSCPX6.22N/A
N/A
Saratoga Small Capitalization I
ITRGX74.03N/A
N/A
VY® T. Rowe Price Growth Equity S2
DHPYX16.55N/A
N/A
Diamond Hill Mid Cap Y